Metastases in the Liver Treatment in Turkey

What Are Metastases in the Liver and Their Common Symptoms?

Metastases in the liver, also known as secondary liver cancer, occur when malignant cells break away from a primary tumour elsewhere in the body and travel through the bloodstream or lymphatic system to settle in the liver tissue. The liver is particularly susceptible to secondary tumours because of its large size and rich blood supply from both the systemic circulation and the portal system draining the digestive tract. Primary cancers that frequently spread to the liver include colorectal, pancreatic, gastric, breast, and lung cancers.

In the early stages, secondary liver lesions may not produce any noticeable signs. However, as the tumours grow or multiply, patients often experience specific symptoms, including:

• Persistent abdominal discomfort or a feeling of fullness in the upper right quadrant
• Unexplained weight loss and reduced appetite
• Chronic fatigue and generalised weakness
• Jaundice, indicated by a yellowing of the skin and whites of the eyes
• Nausea, vomiting, or persistent abdominal swelling (ascites)
• Dark urine and pale-coloured stools

Because these symptoms can overlap with other conditions of the digestive system, a thorough evaluation by a specialist in oncology or gastroenterology is essential to establish an accurate diagnosis.

How Are Liver Metastases Diagnosed in Turkey?

When seeking an evaluation in Turkey, hospitals follow standardized diagnostic protocols to confirm the presence, location, and extent of liver lesions. Medical teams evaluate whether the tumours are isolated to specific segments of the liver or widespread throughout the organ.

International patients traveling for diagnostic assessments are generally asked to bring complete medical files from their home country. Useful records include prior histology reports, recent blood test results, tumour marker trends (such as CEA, CA 19-9, or CA 15-3), and DICOM files of previous imaging scans. Upon arrival, the local oncology team typically conducts:

• High-Resolution Cross-Sectional Imaging: Contrast-enhanced Computed Tomography (CT) scans of the chest, abdomen, and pelvis, or dedicated Magnetic Resonance Imaging (MRI) with liver-specific contrast agents to map the lesions.
• Positron Emission Tomography (PET-CT): To assess metabolic activity throughout the body and rule out or identify metastases in other organs.
• Comprehensive Blood Work: Complete liver function tests (LFTs), coagulation profiles, and baseline blood counts.
• Image-Guided Biopsy: If histological verification is necessary and has not been performed previously, a tissue sample may be obtained under ultrasound or CT guidance.

Treatment Options for Metastases in the Liver

Management strategies depend heavily on the primary cancer type, the number and size of the liver lesions, overall liver function, and the patient's general health status. Treatment decisions are made by a multidisciplinary tumour board comprising oncologists, HPB (hepato-pancreato-biliary) surgeons, and interventional radiologists.

Depending on the primary site, additional procedures from specialized departments such as pulmonology & thoracic surgery or urology may be integrated into the broader care plan if multi-organ involvement is present.

Planning Your Treatment in Turkey

Traveling abroad for complex cancer care requires structured coordination. Before traveling, international care teams conduct a preliminary remote review of your imaging and medical records. This helps outline potential diagnostic steps and tentative care pathways before you leave home.

The required length of stay in Turkey varies according to the chosen intervention:

• Diagnostic Workup & Biopsy: Typically requires 5 to 7 days.
• Interventional Radiology (Ablation/Embolisation): Usually requires 7 to 10 days, including post-procedure observation.
• Major Liver Surgery: Often demands 2 to 3 weeks, combining inpatient hospitalization and outpatient monitoring before cleared to fly.

Before returning home, patients receive detailed medical summaries, updated imaging files, and clear instructions for follow-up care. Continued care, including routine monitoring and maintenance therapies, is managed in coordination with your local oncologist.

When Travel Is Not Advisable and Warning Signs

International travel for advanced liver conditions carries inherent medical risks. Flying or undertaking long journeys is generally not advisable for patients with severe liver failure, unmanageable ascites, severe bleeding disorders, or extreme physical weakness. Decisions regarding travel suitability must be confirmed by your attending physician after reviewing up-to-date clinical reports.

Seek immediate local medical emergency care if you experience any of the following warning signs:

• Sudden onset of severe abdominal pain or abdominal swelling
• High fever accompanied by chills or rigours
• Acute worsening of jaundice (yellowing of eyes/skin) or confusion (encephalopathy)
• Vomiting blood or passing black, tarry stools
• Shortness of breath or chest pain